Biotechnology
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 19, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company"; stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced the adv...
2023-06-19 21:29
3666
Allgenesis Announces Encouraging Phase 1b Data Showing AG-80308 Providing Improvements in Multiple Signs and Symptoms in Dry Eye Patients
ALHAMBRA, Calif., June 19, 2023 /PRNewswire/ -- Allgenesis Biotherapeutics Inc., a clinical-stage specialty pharmaceutical company focused on developing novel ophthalmic drugs, today announced topline data from the company's Phase1b clinical trial for AG-80308, a first-in-class, formyl peptide re...
2023-06-19 16:00
1452
First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion
MELBOURNE, Australia, June 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II study of the Company's carbonic anhydrase- (CAIX)-targeting PET/CT[1] imaging agent TLX250-CDx (89Zr-DFO-girentuxima...
2023-06-19 08:16
1727
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
HONG KONG, June 16, 2023 /PRNewswire/ -- On June 11, 2023, Viva Biotech Holdings Group (1873.HK) announced that Viva Shanghai, the primary entity for Viva Biotech's CRO business, successfully raised nearlyUS$ 150 million through the transfer of approximately 24% of its equity interest to Temasek,...
2023-06-16 14:20
5539
NABR Files Petition Challenging the Listing of Long-Tailed Macaque by the IUCN
WASHINGTON, June 16, 2023 /PRNewswire/ -- Working with recognized, independent scientists, the National Association for Biomedical Research (NABR) filed a petition today with the International Union for Conservation of Nature (IUCN) challenging the recent designation of the long-tailed macaque (C...
2023-06-16 10:30
4759
Everest Medicines Appoints Dr. Mike Berry as Chief Technology Officer
SHANGHAI, June 16, 2023 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on development, manufacturing and commercialization of innovative medicines and vaccines, today announced that Dr.Mike Berry has been appointed Chief Techno...
2023-06-16 07:45
2508
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall
* Novavax has developed a protein-based monovalent XBB.1.5 COVID vaccine candidate and is manufacturing at commercial scale with the intent to be in market during the fall vaccination campaign * Novavax shared data demonstrating that its XBB.1.5 COVID vaccine candidate induces functional immu...
2023-06-16 06:05
2548
TANDEM study shows potential of HistoIndex SHG/TPE imaging and AI-based technology in evaluating the effects of combination therapy for NASH
SINGAPORE, June 15, 2023 /PRNewswire/ -- Recent findings from the TANDEM study (NCT03517540) in 193 patients with nonalcoholic steatohepatitis (NASH) reveal the use of HistoIndex's Second Harmonic Generation/Two-Photon Excitation (SHG/TPE) imaging and Artificial Intelligence (AI) in providing mec...
2023-06-15 20:00
1813
Singapore Hosts the 25th World Congress of Dermatology - The First in Southeast Asia Featuring 10,000 Global Experts to Discuss New Developments in Skin Research and Treatment
Themed 'Dermatology Beyond Borders', WCD2023 is one of the largest international medical conventions in the region, and is set to gather over 10,000 local and foreign delegates, including clinicians, scientists, other health-care professionals and industry partners across 130 countries to unveil ...
2023-06-15 16:07
2112
EW Group Signs with China's Largest Healthcare, Sinopharm
PETALING JAYA, Malaysia, June 15, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group), announced its partnership with HK VJM Ltd (representing Sinopharm Cloud Health Technology (Guandong) Co. and Sinopharm Traditional Chinese Medicine (Foshan) Co.) and NCL Solutions Sdn Bhd onApril...
2023-06-15 10:24
3190
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1 study of their oral small-molecule glucagon-like peptide 1 receptor agonist (...
2023-06-14 20:00
2504
Sirnaomics to Present Latest Developments on GalAhead™ Therapeutic Platform at Upcoming Industry Conferences
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 14, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company"; stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that the...
2023-06-14 00:42
2407
Metabolon Announces Three Oral Presentations and Two Poster Presentations at the 2023 Metabolomics Society Annual Conference
MORRISVILLE, N.C., June 13, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today announced three oral presentations and two poster prese...
2023-06-13 20:57
1646
Taipei Entrepreneurs Hub Focuses on the Greater Health Industries, Taipei City Government Facilitates Global Talents Matchmaking
TAIPEI, June 12, 2023 /PRNewswire/ -- The Taipei City Government continues to promote the "Talent Exchange Program" in support of international entrepreneurs collaborating with companies inTaipei. Serving as the international startup community brand, Taipei Entrepreneurs Hub (TEH) is set to kick ...
2023-06-12 16:12
2037
Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, June 12, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...
2023-06-12 08:00
5311
DxVx, won the governmental project to develop diagnostic sensor kit for adult diseases
* National Project converging semiconductor and biotechnology SEOUL, South Korea, June 9, 2023 /PRNewswire/ -- DxVx announced today that it won the national project, 'Korea-led K-Sensor Technology Development for Market Leadership' supported by the Ministry of Trade, Industry and Energy and man...
2023-06-09 21:00
4501
Investor Open Day: Fosun Implements Business Streamlining and Resilience Building Strategy, Focusing on Core Businesses to Bring New Vitality
HONG KONG, June 9, 2023 /PRNewswire/ -- On 8 June 2023, the 2023 Fosun International Investor Open Day was held inShanghai. It was the first time that Fosun International had held a large-scale offline open day after the pandemic. More than 100 domestic and foreign investor representatives from B...
2023-06-09 11:16
4478
DNAnexus® Applauded by Frost & Sullivan for Supporting Better Clinical Decision-making and More Effective Therapies
Since 2013, DNAnexus has led the market in cloud computing and bioinformatics platforms that handle complex data processing for genomics and multi-omics, counting more than 100 enterprise customers worldwide. SAN ANTONIO, June 8, 2023 /PRNewswire/ -- Frost & Sullivan's recent analysis of the pre...
2023-06-08 20:00
2397
From infinite recycling to bat-like vision for blind people: Cicada Innovations announces the Tech23 startups
SYDNEY, June 8, 2023 /PRNewswire/ -- Australia's flagship deep tech incubator
Cicada Innovations
2023-06-08 15:45
2656
Qilu Pharmaceutical Announces Trials in Progress Posters on QL1706 in Phase III NSCLC Clinical Research at ASCO 2023
JINAN, China, June 8, 2023 /PRNewswire/ -- Recently, Qilu Pharmaceutical presented a Trials in Progress poster presentation on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, in two Phase III non-small cell lung carcinoma (NSCLC) clinical studies at the ...
2023-06-08 15:35
2149
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2928
